ABCL- Abcellera Biologics Inc.

Name: Abcellera Biologics Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Abcellera Biologics Inc. (ABCL) has 8 insiders with recent SEC Form 4 filings, including 6 buys and 7 sells. ABCL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Thermopylae Holdings Ltd.	56.13M	$310.42M	-
CEO	Hansen Carl L. G.	13.10M	$72.43M	-
CFO	Booth Andrew	8.75M	$48.40M	-
Other	Lecault Veronique	5.20M	$28.76M	-
Other	Stimart Tryn	4.65M	$25.69M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 9, 2021	Hansen Carl L. G.	Chief Executive Officer	Sell	6,000,000	$24.13	$144,770,322.60	-9.7%	-20.5%	-64.8%
Jun 9, 2021	Lecault Veronique48	Chief Operating Officer	Sell	1,000,000	$25.50	$25,500,000.00	-78.5%	-20.5%	-64.8%
Jun 9, 2021	Stimart Tryn	Chief Legal Officer	Sell	1,000,000	$25.50	$25,500,000.00	-100.0%	-20.5%	-64.8%
Jun 9, 2021	Falconer Ester	Chief Technology Officer	Sell	1,000,000	$25.50	$25,500,000.00	-100%	-20.5%	-64.8%
Jun 9, 2021	Booth Andrew	Chief Financial Officer	Sell	1,200,000	$25.50	$30,600,000.00	-100%	-20.5%	-64.8%
Jun 9, 2021	Thermopylae Holdings Ltd.63	10% Owner	Sell	5,598,420	$24.03	$134,530,032.60	-9.1%	-20.5%	-64.8%
Dec 15, 2020	Montalbano John S.52	Director	Buy	25,000	$20.00	$500,000.00	New	-	-
Dec 15, 2020	Thiel Peter	Director	Buy	3,000,000	$20.00	$60,000,000.00	+41.8%	-	-
Dec 15, 2020	Hayden Michael R58	Director	Buy	73,665	$20.00	$1,473,300.00	+165.2%	-	-
Dec 15, 2020	Stimart Tryn	Chief Legal Officer	Buy	500	$20.00	$10,000.00	New	-	-

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC